119 HCON 118 IH: Designating September 2026, as “Gynecologic Cancers Awareness Month”. U.S. House of Representatives 2026-09-16 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

IV119th CONGRESS2d SessionH. CON. RES. 118IN THE HOUSE OF REPRESENTATIVESSeptember 16, 2026Mrs. Dingell (for herself and Mr. Bacon) submitted the following concurrent resolution; which was referred to the Committee on Energy and CommerceCONCURRENT RESOLUTIONDesignating September 2026, as Gynecologic Cancers Awareness Month.

Whereas gynecologic cancers include cervical, ovarian, endometrial/uterine, vaginal, and vulvar cancers with the first 3 being the most common; Whereas there are approximately 117,660 new cases of these cancers diagnosed and approximately 34,570 deaths from gynecologic cancers annually; Whereas endometrial cancer is one of the few cancers with rising incidence and mortality rates; Whereas endometrial and ovarian cancer rank fourth and sixth in cancer deaths among women, respectively; Whereas symptoms are often vague or misunderstood and there are no screening tests to identify endometrial and ovarian cancers before they progress to later stages; Whereas cervical cancer is the only gynecologic cancer with a reliable screening test and is vaccine-preventable; Whereas increased awareness of gynecologic cancers can lead to earlier diagnosis, follow-up with appropriate health professionals, and improved outcomes; and Whereas the Foundation for Women’s Cancer and other organizations celebrate September 2026 as Gynecologic Cancers Awareness Month: Now, therefore, be it

That Congress— (1)supports the designation of Gynecologic Cancers Awareness Month; (2)supports the goals and ideals of Gynecologic Cancers Awareness Month; (3)recognizes and affirms the commitment of the United States to reducing the burden of these cancers on women by— (A)promoting awareness about the causes, risks, and prevention of gynecologic cancers; (B)supporting research on gynecologic cancers; and (C)taking other steps to improve health outcomes associated with these cancers and reduce associated mortality; and (4)encourages every person in the United States to learn about the risk for gynecologic cancers.